Impact of chronic constipation and IBS

Advanced Studies in Medicine

Volumn 6, Issue 2 A, 2006, Pages

  Chang, Lin ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALOSETRON; DESIPRAMINE; LEUPRORELIN;

BEHAVIOR THERAPY; CHRONIC DISEASE; CLINICAL TRIAL; COGNITIVE THERAPY; CONFERENCE PAPER; CONSTIPATION; DAILY LIFE ACTIVITY; DEMOGRAPHY; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH ECONOMICS; HUMAN; IRRITABLE COLON; PREVALENCE; PRODUCTIVITY; QUALITY OF LIFE; RISK FACTOR; SYMPTOMATOLOGY;

EID: 33645576459     PISSN: 15303004     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (51)

1. Corazziari E. Definition and epidemiology of functional gastrointestinal disorders. Best Pract Res Clin Gastroenterol. 2004;18:613-631.
2. Higgins PD, Johanson JF. Epidemiology of constipation in North America: a systematic review. Am J Gastroenterol. 2004;99:750-759.
3. Brandt LJ, Bjorkman D, Fennerly MB, et al. Systematic review on the management of irritable bowel syndrome in North America. Am J Gastroenterol. 2002;97(11, suppl):S7-S26.
4. Wong WM, Fass R. Noncardiac chest pain. Curr Treat Options Gastroenterol. 2004;7:273-278.
5. Centers for Disease Control and Prevention (CDC). Prevalence of diabetes and impaired fasting glucose in adults - United States, 1999-2000. MMWR Morb Mortal Wkly Rep. 2003;52:833-837.
6. Centers for Disease Control and Prevention (CDC). Asthma prevalence and control characteristics by race/ethnicity - United States, 2002. MMWR Morb Mortal Wkly Rep. 2004;53:145-148.
7. Lawrence EC. Diagnosis and management of migraine headaches. South Med J. 2004;97:1069-1077.
8. Wolf-Maier K, Cooper RS, Banegas JR, et al. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA. 2003;289:2363-2369.
9. Stewart WF, Liberman JN, Sandler RS, et al. Epidemiology of Constipation (EPOC) study in the United States: relation of clinical subtypes to sociodemographic features. Am J Gastroenterol. 1999;94:3530-3540.
10. Talley NJ, Fleming KC, Evans JM, et al. Constipation in an elderly community: a study of prevalence and potential risk factors. Am J Gastroenterol. 1996;91:19-25.
11. Paré P, Ferrazzi S, Thompson WG, et al. An epidemiological survey of constipation in Canada: definitions, rates, demographics, and predictors of health care seeking. Am J Gastroenterol. 2001;96:3130-3137.
12. Johanson JF, Sonnenberg A, Koch TR. Clinical epidemiology of chronic constipation. J Clin Gastroenterol. 1989;11:525-536.
13. Everhart JE, Go VL, Johannes RS, et al. A longitudinal survey of self-reported bowel habits in the United States. Dig Dis Sci. 1989;34:1153-1162.
14. Heaton KW, Radvan J, Cripps H, et al. Defecation frequency and timing, and stool form in the general population: a prospective study. Gut. 1992;33:818-824.
15. Locke GR 3rd, Zinsmeister AR, Fett SL, et al. Overlap of gastrointestinal symptom complexes in a US community. Neurogastroenterol Motil. 2005;17:29-34.
16. Talley NJ, Dennis EH, Schettler-Duncan VA, et al. Overlapping upper and lower gastrointestinal symptoms in irritable bowel syndrome patients with constipation or diarrhea. Am J Gastroenterol. 2003;98:2454-2459.
17. Candelli M, Nista EC, Zocco MA, Gasbarrini A. Idiopathic chronic constipation: pathophysiology, diagnosis and treatment. Hepatogastroenterology. 2001;48:1050-1057.
18. Locke GR 3rd, Pemberton JH, Phillips SF. AGA technical review on constipation. American Gastroenterological Association. Gastroenterology. 2000;119:1766-1778.
19. Lembo A, Camilleri M. Chronic constipation. N Engl J Med. 2003;349:1360-1368.
20. Thompson WG, Longstreth GF, Drossman DA, et al. Functional bowel disorders and functional abdominal pain. Gut. 1999;45(suppl 2):1143-1147.
21. Brandt IJ, Prather CM, Quigley EM, et al. Systematic review on the management of chronic constipation in North America. Am J Gastroenterol. 2005;100(suppl 1):S5-S21.
22. Drossman DA, Whitehead WE, Camilleri M. Irritable bowel syndrome: a technical review for practice guideline development. Gastroenterology. 1997;112:2120-2137.
23. Liebman Research, Inc. IBS Sufferers Attitude and Symptom Profile study; 2000.
24. Irvine EJ, Ferrazzi S, Paré P, et al. Health-related quality of life in functional GI disorders: focus on constipation and resource utilization. Am J Gastroenterol. 2002;97:1986-1993.
25. Sonnenberg A, Koch TR. Physician visits in the United States for constipation: 1958 to 1986. Dig Dis Sci. 1989;34:606-611.
26. Dennison C, Prasad M, Lloyd A, et al. The health-related quality of life and economic burden of constipation. Pharmacoeconomics. 2005;23:461-470.
27. Pekmazaris R, Aversa L, Wolf-Klein G, et al. The cost of chronic constipation. J Am Med Dir Assoc. 2002;3:224-228.
28. Rantis PC Jr, Vernava AM 3rd, Daniel GL, Longo WE. Chronic constipation-is the work-up worth the cost? Dis Colon Rectum. 1997;40:280-286.
29. Drossman DA, Camilleri M, Mayer EA, Whitehead WE. AGA technical review on irritable bowel syndrome. Gastroenterology. 2002;123:2108-2131.
30. Drossman DA, Li Z, Andruzzi E, et al. US householder survey of functional gastrointestina disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci. 1993;38:1569-1580.
31. Hu WH, Wong WM, Lam CL, et al. Anxiety but not depression determines health care-seeking behaviour in Chinese patients with dyspepsia and irritable bowel syndrome: a population-based study. Aliment Pharmacol Ther. 2002;16:2081-2088.
32. Thompson WG, Irvine EJ, Paré P, et al. Functional gastrointestinal disorders in Canada: first population-based survey using Rome II criteria with suggestions for improving the questionnaire. Dig Dis Sci. 2002;47:225-235.
33. Muller-Lissner SA, Bollani S, Brummer RJ, et al. Epidemiological aspects of irritable bowel syndrome in Europe and North America. Digestion. 2001;64:200-204.
34. Talley NJ, Zinsmeister AR, Melton IJ 3rd. Irritable bowel syndrome in a community: symptom subgroups, risk factors, and health care utilization. Am J Epidemiol. 1995;142:76-83.
35. Mitchell CM, Drossman DA. Survey of the AGA membership relating to patients with functional gastrointestinal disorders. Gastroenterology. 1987;92:1282-1284.
36. Frank L, Kleinman L, Rentz A, et al. Health-related quality of life associated with irritable bowel syndrome: comparison with other chronic diseases. Clin Ther. 2002;24:675-689.
37. Hahn BA, Yan S, Strassels S. Impact of irritable bowel syndrome on quality of life and resource use in the United States and United Kingdom. Digestion. 1999;60:77-81.
38. Spiegel BM, Gralnek IM, Bolus R, et al. Clinical determinants of health-related quality of life in patients with irritable bowel syndrome. Arch Intern Med. 2004;164:1773-1780.
39. Mathias JR, Clench MH, Abell TL, et al. Effect of leuprolide acetate in treatment of abdominal pain and nausea in premenopausal women with functional bowel disease: a double-blind, placebo-controlled, randomized study. Dig Dis Sci. 1998;43:1347-1355.
40. Drossman DA, Toner BB, Whitehead WE, et al. Cognitive-behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders. Gastroenterology. 2003;125:19-31.
41. Watson ME, Lacey L, Kong S, et al. Alosetron improves quality of life in women with diarrhea-predominant irritable bowel syndrome. Am J Gastroenterol. 2001;96:455-459.
42. Heymann-Monnikes I, Arnold R, Florin I, et al. The combination of medical treatment plus multicomponent behavioral therapy is superior to medical treatment alone in the therapy of irritable bowel syndrome. Am J Gastroenterol. 2000;95:981-994.
43. Chang L. Review article: epidemiology and quality of life in functional gastrointestinal disorders. Aliment Pharmacol Ther. 2004;20(suppl 7):31-39.
44. Sandler RS, Everhart JE, Donowitz M, et al. The burden of selected digestive diseases in the United States. Gastroenterology. 2002;122:1500-1511.
45. Levy RL, Von Korff M, Whitehead WE, et al. Costs of care for irritable bowel syndrome patients in a health maintenance organization. Am J Gastroenterol. 2001;96:3122-3129.
46. Longstreth GF, Wilson A, Knight K, et al. Irritable bowel syndrome, health care use, and costs: a U.S. managed care perspective. Am J Gastroentetol. 2003;98:600-607.
47. Martin BC, Ganguly R, Pannicker S, et al. Utilization patterns and net direct medical cost to Medicaid of irritable bowel syndrome. Curr Med Res Opin. 2003;19:771-780.
48. Bharucha AE, Locke GR 3rd, Zinsmeister AR, et al. Differences between painless and painful constipation among community women. Am J Gastroenterol. In press.
49. Robson KM, Kiely DK, Lembo T. Development of constipation in nursing home residents. Dis Colon Rectum. 2000;43:940-943.
50. Whitehead WE, Drinkwater D, Cheskin LJ, et al. Constipation in the elderly living at home. Definition, prevalence, and relationship to lifestyle and health values. J Am Geriatr Soc. 1989;37:423-429.
51. Talley NJ, Weaver AL, Zinsmeister AR, Melton LJ 3rd. Functional constipation and outlet delay: a population-based study. Gastroenterology. 1993;105:781-790.